Newcomer Lee Nisley 4

What Happened

• Lee Nisley, a director of Myriad Genetics, was awarded 59,701 restricted stock units (RSUs) on June 4, 2026. The grant was reported on Form 4 filed June 5, 2026. The RSUs were granted at $0.00 per unit (no cash exchanged) and therefore have a reported transaction value of $0.

Key Details

• Transaction date: 2026-06-04; Filing date: 2026-06-05.
• Award type/code: A (grant/award/acquisition) — 59,701 RSUs at $0.00.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: RSUs were granted under the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each RSU represents a contingent right to one share and vests upon the earlier of (a) the first anniversary of the grant or (b) the date of the next annual meeting of stockholders following the grant.
• Filing timeliness: Reported the day after the transaction (appears timely under usual Form 4 rules).

Context

• RSUs are a deferred-compensation award that convert into common shares upon vesting; they are not an immediate cash purchase or sale. Such grants to directors are common as part of compensation and do not by themselves indicate a buy/sell signal.